about
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transitionCarotid endarterectomy for carotid stenosis in patients selected for coronary artery bypass graft surgeryAndrogen-induced cerebral venous sinus thrombosis in a young body builder: case reportIranian consensus on use of vitamin D in patients with multiple sclerosisMultiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic ReviewDifferential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical PatternsPrevalence of multiple sclerosis in Iranian emigrants: review of the evidence.Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments.The role of the cerebellum in multiple sclerosis.Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis.Potential role of immunoglobulin replacement therapy on MRI measures in multiple sclerosis: a systematic review.Black holes in multiple sclerosis: definition, evolution, and clinical correlations.Role of MRI in diagnosis and treatment of multiple sclerosis.Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran.Clinical and Epidemiological Aspects of Multiple Sclerosis in Children.The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 miceProgressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis.Determinants of sexual dysfunction in women with multiple sclerosis.Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease.Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.Relationship between Sleep Quality and Quality of Life in Patients with Multiple Sclerosis.Islamic fasting and multiple sclerosis.Comparison of serum vitamin D level in multiple sclerosis patients, their siblings, and healthy controls.Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy.Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis.The effect of vitamin A supplementation on stimulated T-cell proliferation with myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.Validity and Reliability of the Persian Version of the PERception de la Scle'rose En Plaques et de ses Pousse'es Questionnaire Evaluating Multiple Sclerosis-related Quality of LifeChannelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.Electrocardiographic abnormalities in acute cerebrovascular events in patients with/without cardiovascular disease.Dalfampridine: review of its efficacy in improving gait in patients with multiple sclerosis.Epidemiology of multiple sclerosis in Qom: Demographic study in IranFuture of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countries.Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.Significant increase in the prevalence of multiple sclerosis in iran in 2011.Blood Concentrations of Cadmium and Lead in Multiple Sclerosis Patients from Iran.Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis.
P50
Q21034169-49D03D60-E60C-45B2-9B2F-342D40E744D8Q24170269-EA190DEC-C745-4C5E-B9BE-D51B6BF1D74FQ24240379-634F1BD7-797F-4A33-8DB4-481C36591C97Q24809789-5464050B-8E8B-40AF-9B61-97FE1FE01C19Q28067025-8D84711F-8A66-4006-A6AD-1D0A7F02973BQ28069707-5D032ABD-7086-48BA-A08F-5B4169B6FC5EQ29391765-211FDA61-6225-4F99-B51C-7124A3E845A6Q30249285-8C8420C8-2F3C-49CD-BA4F-199779CFB479Q30276050-BD092639-A6F5-4D58-9786-E286A3DBF589Q30358426-18E63E1F-E3C4-472C-8198-701A0BFC009DQ30409179-8D182C85-2089-4199-8169-399095E4A10CQ30651607-60B4D4A0-BA51-4E78-9393-800D98FA4414Q30884001-464ED1D8-6015-4C9A-875F-A27AB8385121Q30885562-1E140399-83EE-4BE0-84FD-BBC9C757FA2CQ31009149-76655D17-5DA0-4889-AC2D-B846EC0B7442Q33517838-CB635D40-E456-45DF-AD71-39B86299830AQ33563582-4DA4C066-19B5-474B-9CA9-6A9940E74007Q33720721-152EDCF5-B52E-4BC2-AB3C-36990D14CF14Q33861610-402E5E0E-4D8F-4479-9AE5-0D1AE79AC734Q34065923-D5B4025D-C92F-410E-BB23-97F864812BF0Q34089586-1403F2D3-E1A8-4A4C-8A84-6F2D777DD47EQ34816183-298FB31D-F6C4-489D-9493-44D199C05413Q35009543-5930457D-1664-44CF-8F24-E06E19039EA2Q35093103-705F71BD-F0D5-4868-9ABA-02BC97674B67Q35109344-24898FC0-C43B-4719-8F6A-F1752CC820DAQ35127335-1D7AD6E4-B1C7-4227-85A7-A02133787546Q35666287-85984B7B-4EBF-4C00-8151-590AB9895118Q35675602-C475A3D9-DCFD-4CD2-88D4-F5FB70474229Q36015388-16752590-08DB-4A8B-A4EC-D2C72897C189Q36420375-011B77DF-D612-4A1E-8620-91361C59697AQ36584574-E4ABF33D-11DF-4BE8-AF87-92334D564CD9Q36638837-322D5E3B-5CF5-497B-978D-6EEF1C0B81B9Q36817762-0716C8F4-CA1F-4C83-B590-E327FCE8BC23Q36873901-81881F79-DBA3-4A5B-87B6-5F47A793211BQ37311807-1F647717-BDEE-4FBB-A2AA-680E1743BEC3Q37424282-791DB79E-E4B8-4336-A913-6DB3D3C8600BQ37504560-9A5833D5-8D43-4FA7-9F67-B45BE3F94C90Q37642258-D6DC963E-404D-4EFC-BDAB-EDD8DF1475DFQ37651121-219ECD9B-ABE3-4C8C-9938-D296A4296D07Q37669992-F8FF90E4-6ECF-4360-9C8E-2DF7E6FB0628
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mohammad Ali Sahraian
@ast
Mohammad Ali Sahraian
@en
Mohammad Ali Sahraian
@es
Mohammad Ali Sahraian
@fr
Mohammad Ali Sahraian
@nl
Mohammad Ali Sahraian
@sl
type
label
Mohammad Ali Sahraian
@ast
Mohammad Ali Sahraian
@en
Mohammad Ali Sahraian
@es
Mohammad Ali Sahraian
@fr
Mohammad Ali Sahraian
@nl
Mohammad Ali Sahraian
@sl
prefLabel
Mohammad Ali Sahraian
@ast
Mohammad Ali Sahraian
@en
Mohammad Ali Sahraian
@es
Mohammad Ali Sahraian
@fr
Mohammad Ali Sahraian
@nl
Mohammad Ali Sahraian
@sl
P106
P1153
55886074600
P21
P31
P496
0000-0002-3224-8807